MetaCap

Axogen Inc. (AXGN)

NASDAQ: AXGNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

55.75-0.60 (-1.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

AXGN stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.63
Ex-dividend date
Jan 27, 2010
52-week range
26.92 – 59.72
Day range
55.03 – 56.91
Volume / Avg
875.45K / 1.57M
Beta
—

52-week range

$26.92$59.72

AXGN stock today

Axogen (AXGN) closed at $55.75 on Nov 20, down 1.06% (-$0.60), versus the S&P 500's 3.70% decline. At this level, AXGN sits near the top of its 52-week range of $26.92 to $59.72: 6.6% below the high, set on Nov 11, 2026 and 107.1% above the low. AXGN is up 70.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 107.5%.

Axogen has posted a net loss over the last twelve months (EPS of -$0.63), so its P/E ratio is not meaningful.

Summary generated from market data by MetaCap's automated system. Methodology

About Axogen

Company profile

Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and wrap damaged peripheral nerves and reinforce reconstructed nerve gaps. It also provides Axoguard HA+ Nerve Protector, a surgical implant for non-constricting protection of the peripheral nerves; Axoguard Nerve Cap, a porcine submucosa ECM product; Avive+ Soft Tissue Matrix, a multi-layer amniotic membrane allograft; and Avance Method, a technique to process Avance Nerve Graft from donated human peripheral nerve tissue.

Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
CEO
Mr. Michael D. Dale
Headquarters
Alachua, FL
Employees
622

Financial highlights

Full financials

In fiscal 2025, Axogen generated $225.2 million in revenue, up 20.2% from fiscal 2024, its 15th consecutive year of revenue growth. Axogen reported a net loss of $15.7 million, compared with a loss of $10.0 million a year earlier. Gross margin was 74.3% (down from 75.8%) and operating margin -3.5%.

Axogen annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$225.21M$187.34M$159.01M$138.58M$127.36M
Growth+20.21%+17.81%+14.74%+8.81%+13.41%
Net income$-15.70M$-9.96M$-21.72M$-28.95M$-26.98M
EPS (diluted)$-0.34$-0.23$-0.51$-0.69$-0.65

Analyst forecast

Forecast

Consensus (11 analysts)

strong_buy

Avg. price target

$59.27+6.31%

  • Strong buy 2
  • Buy 9
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $56.00High $65.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 28, 2026
EPS actual vs est.
$0.04 vs $-0.03
Surprise
+233.33%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$1.00
Ex-dividend date
Jan 27, 2010

AXGN news

All AXGN news

Axogen peers

Health Care sector
AXGN peer companies
CompanyPrice% ChgMarket capCompare
TMDXTransMedics Group Inc.85.25-9.33%$2.96Bvs AXGN
LIVNLivaNova PLC90.73-1.46%$5.00Bvs AXGN
CNMDCONMED Corporation46.56+0.39%$1.39Bvs AXGN
CBLLCeriBell Inc.27.39+6.37%$1.06Bvs AXGN
INMDInMode Ltd.12.42-2.20%$714.70Mvs AXGN
CVCapsoVision Inc.6.11-3.17%$327.56Mvs AXGN
ELMDElectromed Inc.22.98-1.20%$187.84Mvs AXGN
FOCLEDAP TMS S.A. ADR2.61-7.45%$123.25Mvs AXGN

Indexes, lists and sector

Axogen stock FAQ

What is Axogen's stock price today?

AXGN last traded at $55.75 as of Nov 20, 4:00 PM EST, down 1.06% on the day. Prices are delayed at least 15 minutes.

Does Axogen pay a dividend?

Yes. Axogen pays $0.00 per share annually. The most recent dividend of $1.00 had an ex-dividend date of Jan 27, 2010.

Who is Axogen's CEO?

Mr. Michael D. Dale is the chief executive officer of Axogen Inc., which has about 622 employees.

Has AXGN ever split its stock?

Yes. The most recent AXGN stock split was a 105-for-100 split on Jul 11, 1994, one of 3 splits on record.

What is the AXGN 52-week high?

The 52-week high for AXGN is $59.72 and the 52-week low is $26.92. The stock is currently 6.6% below its high.

Compare AXGN